Safety and dose modification for patients receiving niraparib.
Berek JS, Matulonis UA, Peen U, Ghatage P, Mahner S, Redondo A, Lesoin A, Colombo N, Vergote I, Rosengarten O, Ledermann J, Pineda M, Ellard S, Sehouli J, Gonzalez-Martin A, Berton-Rigaud D, Madry R, Reinthaller A, Hazard S, Guo W, Mirza MR.
Berek JS, et al.
Ann Oncol. 2019 May 1;30(5):859. doi: 10.1093/annonc/mdy255.
Ann Oncol. 2019.
PMID: 30107447
Free article.
No abstract available.